A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita

scientific article published on 16 January 2012

A reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1051054438
P356DOI10.1038/BMT.2011.257
P698PubMed publication ID22246089

P50authorAli BazarbachiQ57964105
P2093author name stringA Bacigalupo
M A Kharfan-Dabaja
Z K Otrock
F Geara
R A Mahfouz
P2860cites workPrevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantationQ33183745
Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working PartyQ33886206
Low-intensity hematopoietic stem-cell transplantation across human leucocyte antigen barriers in dyskeratosis congenitaQ35128245
Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.Q53330217
Dyskeratosis congenitaQ58388056
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenitaQ71045172
Fatal interstitial pulmonary disease in a patient with dyskeratosis congenita after allogeneic bone marrow transplantationQ73112262
Unusual complications after bone marrow transplantation for dyskeratosis congenitaQ77476844
Allogeneic stem cell transplantation in a patient with dyskeratosis congenita after conditioning with low-dose cyclophosphamide and anti-thymocyte globulinQ81552159
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectdyskeratosis congenitaQ3709312
hematologyQ103824
P304page(s)1254-1255
P577publication date2012-01-16
P1433published inBone Marrow TransplantationQ4941523
P1476titleA reduced intensity conditioning regimen of fludarabine, cyclophosphamide, antithymocyte globulin, plus 2 Gy TBI facilitates successful hematopoietic cell engraftment in an adult with dyskeratosis congenita
P478volume47

Reverse relations

cites work (P2860)
Q36782745A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation
Q90485045Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia
Q46177519Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure.
Q87154630Reduced intensity conditioning regimen with fludarabine, cyclophosphamide, low dose TBI and alemtuzumab leading to successful unrelated umbilical cord stem cell engraftment and survival in two children with dyskeratosis congenita
Q34094121The diagnosis and treatment of dyskeratosis congenita: a review

Search more.